TELEBRIX 38 ORAL 255 MG — DIN 02131684
SODIUM IOXITALAMATE : 255 MG MEGLUMINE IOXITALAMATE : 513 MG · LIEBEL-FLARSHEIM CANADA INC · SOLUTION · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is TELEBRIX 38 ORAL?
TELEBRIX 38 ORAL 255 MG contains SODIUM IOXITALAMATE : 255 MG MEGLUMINE IOXITALAMATE : 513 MG. It is listed in the Health Canada Drug Product Database under DIN 02131684, held by LIEBEL-FLARSHEIM CANADA INC, supplied as SOLUTION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 07-Aug-2020. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
What is TELEBRIX 38 ORAL used for?
Bowel opacifier during CT scanning of the abdomen and pelvis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 255 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | ORAL |
| Pack configuration (monograph) | Available in 30 mL and 120 mL bottles. |
| Storage | Store at 15°C to 30°C. Do not freeze. Protect from light. Diluted solution stable for 2 weeks at room temperature, but 48 hours recommended. |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Ioxitalamic Acid |
|---|---|
| ATC code | V08AA05 |
| AHFS class | 36:68.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02131684 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2131684 |
| Brand name | TELEBRIX 38 ORAL |
| Generic / active ingredient | SODIUM IOXITALAMATE : 255 MG MEGLUMINE IOXITALAMATE : 513 MG |
| Market authorization holder | LIEBEL-FLARSHEIM CANADA INC |
| Health Canada schedule | Ethical |
| ATC code | V08AA05 |
| ATC anatomical main group | V — Various |
| ATC therapeutic subgroup | V08AA |
| Current status | CANCELLED POST MARKET |
| Status date | 07-Aug-2020 |
| Original market date | 1995-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Must be diluted to 2% w/v (e.g., 12 mL in 450 mL water). Adults: 450-1050 mL total depending on organ. Children 1-12: max 8 mL/kg or 400 mL total. Administered in small aliquots over time.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to ioxitalamate acid salts; severe oliguria or anuria; history of major skin reactions; suspected broncho-esophageal fistula or aspiration risk; manifest thyrotoxicosis.
Warnings and precautions
Do not inject. Risk of life-threatening hypersensitivity/anaphylaxis. Increased absorption if GI mucosa is altered. May induce thyroid dysfunction. Ensure resuscitation equipment is available.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
2 · Same class — other molecules in ATC V08AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Diatrizoic Acid | GASTROGRAFIN · GASTROGRAFIN LIQ · HYPAQUE ORAL LIQUID - 50G/120ML · HYPAQUE ORAL LIQUID 50GM/120ML · +26 more | 30 | 1 | Yes |
| Iotalamic Acid | CONRAY 30 · CONRAY 325 · CONRAY 400 · CONRAY 43 · +4 more | 8 | 0 | Not in Canada |
| Watersol., Nephrotropic, High Osm. X-Ray Contr. Media | SINOGRAFIN · SINOGRAFIN - LIQ IU | 2 | 0 | Not in Canada |
| Ioxitalamic Acid | TELEBRIX 38 ORAL | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC V08A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| V08AB | Iodixanol · Iohexol · Iopamidol · Iopromide · Iotrolan · +2 more | 45 | 14 |
| V08AD | Ethyl Esters Of Iodised Fatty Acids · Iopydol | 2 | 1 |
| V08AC | Adipiodone · Iopanoic Acid · Sodium Iopodate | 6 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.